Title: HIDDEN VALUE OF PRIOR AUTHORIZATION (PA); REIMBURSEMENT OF OUTCOMES AND ESTIMATED SAVINGS FOLLOWING A POINT-OF-SALE REJECTION FOR VARIOUS PA DRUGS